Skip to main content

Table 3 SNAP-25 rs353050 genotype distribution of the individuals enrolled in the study (overall and severely sarcopenic patient undergoing rehabilitation in which circulatory miRNAs were analyzed)

From: Sarcopenia associates with SNAP-25 SNPs and a miRNAs profile which is modulated by structured rehabilitation treatment

SNAP-25 rs363050* Sarcopenic patients Healthy controls
Overall group n. 177 n. 181
 AA** 71 (40%) 48 (27%)
 AG 73 (41%) 109 (60%)
 GG 33 (19%) 24 (13%)
Severely sarcopenic patients undergoing rehabilitation n. 45 n. 44
 AA 17 (38%) 15 (33%)
 AG 22 (49%) 25 (57%)
 GG 6 (13%) 4 (10%)
  1. Genotype distribution is reported as absolute number and percentage of subjects
  2. * p = 0.001; d.f.: 2; χ2 = 12.94;
  3. ** pc = 0.01; OR = 1.85; 95% CI 1.19–2.90